Pharmaceutical care is an essential component of mental healthcare.
Objectives:
The study assessed pharmacists’ collaborations, barriers, perceptions on therapeutic relationships and attitudes toward pharmaceutical care to persons with mental illness.
Methods:
A questionnaire-based descriptive cross-sectional survey was conducted among 175 pharmacists in a Nigerian state via purposive sampling. Average mean score of >3 (±SD) was considered positive attitude toward pharmaceutical care, and positive for respondents’ perception of pharmacists-patient relationship during consultations. Data were analyzed using SPSS version 25.0 for descriptive statistics.
Results:
A total of 140 (80.0%) respondents participated in the study. Access to patients’ medical records 90 (64.3%) was the major barrier to the provision of pharmaceutical care to persons with mental illness. Almost half of the study participants 69 (49.3%) desired collaboration with only general practitioners and psychiatrists. Only 44 (31.4%) had full co-operation from their desired collaborators. Average score for respondents’ attitude toward provision of pharmaceutical care to the patients, and perception of pharmacist-patient relationship were 4.5 (±0.7) and 3.8 (±0.9) respectively.
Conclusions:
Study participants’ attitude toward pharmaceutical care, and perception on therapeutic relationship in persons with mental disorder were positive. Lack of access to patients’ records mostly hindered provision of pharmaceutical care, and full collaboration with other mental health experts was mostly lacking. Appropriate policies are required to improve these vital components of mental healthcare for desired outcomes.
SilvaBBFegadolliC.Implementation of pharmaceutical care for older adults in the brazilian public health system: a case study and realistic evaluation. BMC Health Serv Res. 2020;20:37. doi:10.1186/s12913-020-4898-z
2.
OsemwenkhaSAkenzuaI.Assessment of the involvement of the community pharmacist in the practice of pharmaceutical care in benin City, Nigeria. J Contemp Res. 2009;6(1):364-371.
3.
EzeUIHAdeyeriOHIheanachoCO. Participation of pharmacy technicians in clinical and patient-centered care practices: a state-wide survey in Nigeria. J Am Pharm Assoc. 2022;62(3):845-852. doi:10.1016/j.japh.2021.11.015
4.
IheanachoCOAdeyeriOEzeUIH. Evolving role of pharmacy technicians in pharmaceutical care services: Involvement in counselling and medication reviews. Explor Res Clin Soc Pharm. 2022;5:100113. doi:10.1016/j.rcsop.2022.100113
5.
Ogadi IheanachoCOdiliUVOluigboKE.Predominant sources of pharmacists’ drug information, and identification of drug information needs from pharmacists in community and hospital settings. Ind J Pharm Pract. 2021;14(1):46-53. doi:10.5530/ijopp.14.1.9
6.
ChongWWAslaniPChenTF.Effectiveness of interventions to improve antidepressant medication adherence: a systematic review. Int J Clin Pract. 2011;65:954-975.
7.
AaltonenSELaineNPVolmerD, et al. Barriers to medication counselling for people with mental health disorders: a six country study. Pharm Pract. 2010;8(2):121-131. doi:10.4321/s1886-36552010000200007
8.
MishraAKrishnaGSAllaS, et al. Impact of pharmacist–psychiatrist collaborative patient education on medication adherence and quality of life (QOL) of bipolar affective disorder (BPAD) patients. Front Pharmacol. 2017;8:722. doi:10.3389/fphar.2017.00722
9.
OdiliVEgieborBOparahC.Identification of drug therapy problems in patients with diabetes treated in a secondary care facility in Benin city. Nig J Pharm Res. 2011;9(1):72-81.
10.
NetoPRMarusicSde Lyra JúniorDP, et al. Effect of a 36-month pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients. J Pharm Pharm Sci. 2011;14(2):249-263. doi:10.18433/j3259q
11.
Rubio-ValeraMMarch PujolMFernándezA, et al. Evaluation of a pharmacist intervention on patients initiating pharmacological treatment for depression. A randomized controlled superiority trial. Eur Neuropsychopharmacol. 2013;23:1057-1066.
12.
JovéAMFernándezAHughesC, et al. Perceptions of collaboration between general practitioners and community pharmacists: findings from a qualitative study based in Spain. J Interprof Care. 2014;28:352-357.
13.
AlbassamAAlmohammedHAlhujailiMKoshySAwadA.Perspectives of primary care physicians and pharmacists on interprofessional collaboration in Kuwait: a quantitative study. PLoS One. 2020;15(7):e0236114. doi:10.1371/journal.pone.0236114
14.
BamgbadeBAFordKHBarnerJC.Impact of a mental illness stigma awareness intervention on pharmacy student attitudes and knowledge. Am J Pharm Educ. 2016;80(5):80. doi:10.5688/ajpe80580
WadaYHRajwaniLAnyamE, et al. Mental health in Nigeria: A neglected issue in public health. Public Health Pract. 2021;2:100166. doi:10.1016/j.puhip.2021.100166
18.
UgochukwuOMbaezueNLawalSA, et al. The time is now: reforming Nigeria’s outdated mental health laws. Lancet Glob Health. 2020;8(8):e989-e990. doi:10.1016/S2214-109X(20)30302-8
19.
SuleimanD.Mental health disorders in Nigeria: a highly neglected disease. Ann Nig Med. 2016;10(2):47-48. doi:10.4103/0331-3131.206214
20.
OgbonnaPNIheanachoPNOgbonnayaNP, et al. Prevalence of mental illness among adolescents (15–18 years) treated at Federal Neurospsychiatric Hospital, Enugu Nigeria, from 2004 to 2013. Arch Psychiatr Nurs. 2020;34(1):7-13. doi:10.1016/j.apnu.2019.12.008
21.
LasebikanVOEjidokunACokerOA.Prevalence of mental disorders and profile of disablement among primary health care service users in Lagos Island. Epidemiol Res Int. 2012;2012:1-6. doi:10.1155/2012/357348
22.
NjakaSEzeruigboC.Prevalence of mental disorder in Abakiliki, Ebonyi State, Southeastern Nigeria. J Am Psychiatr Nurses Assoc. 2022;28(4):306-318. doi:10.1177/1078390320951910
23.
UdohAAkpanMIbrahimUI, et al. Clinical pharmacy services provided in public sector hospitals in Nigeria: a national survey. Int J Pharm Pract. 2021;29(5):471-479. doi:10.1093/ijpp/riab046
24.
MohammedEMcDonaldWGEzikeAC.Teamwork in health care services delivery in Nigeria: a mixed methods assessment of perceptions and lived experiences of pharmacists in a tertiary hospital. Integr Pharm Res Pract. 2022;11:33-45. doi:10.2147/iprp.s331041
ShamiRAlamMFElHajjMS.The role of community pharmacists in depression management: a survey of attitudes, practices and perceived barriers. Int J Clin Pharm. 2022;44:214-226. doi:10.1007/s11096-021-01337-9
27.
Owusu-DaakuFTMarfoAFBoatengEA.The contribution of Ghanaian pharmacists to mental healthcare: current practice and barriers. Int J Ment Health Syst. 2010;4:14. doi:10.1186/1752-4458-4-14
28.
GoodmanCSSmithTJLaMotteJM.A survey of pharmacists’ perceptions of the adequacy of their training for addressing mental health-related medication issues. Ment Health Clin. 2017;7(2):69-73. doi:10.9740/mhc.2017.03.069
29.
EzeUIHTugboboAOIheanachoCO. Pharmacy students’ perceptions of collaborations, barriers, and attitude towards patient-centred care in persons with mental disorder in south-west Nigeria. Pharm Educ. 2021;21(1):723-730. doi:10.46542/pe.2021.211.723730
30.
OkoroRAuwalM.Hospital pharmacists’ participation in multidisciplinary ward rounds: physicians’ perceptions and attitudes. J Pharm Res Int. 2015;5(5):319-327.
31.
RugkåsaJTveitOGBerteigJHussainARuudT.Collaborative care for mental health: a qualitative study of the experiences of patients and health professionals. BMC Health Serv Res. 2020;20(1):844. doi:10.1186/s12913-020-05691-8
32.
SaraivaSBachmannMAndradeMLiriaA.Bridging the mental health treatment gap: effects of a collaborative care intervention (matrix support) in the detection and treatment of mental disorders in a Brazilian city. Fam Med Community Health. 2020;8(4):e000263. doi:10.1136/fmch-2019-000263
33.
Rubio-ValeraMChenTFO’ReillyCL.New roles for pharmacists in community mental health care: a narrative review. Int J Environ Res Public Health. 2014;11(10):990. doi:10.3390/ijerph111010967
34.
IheanachoCOOdiliVU.Job satisfaction among pharmacists practicing in benin City, Nigeria. Trop J Pharm Res. 2022;20(8):1721-1728. doi:10.4314/tjpr.v20i8.25
35.
CatesMEBurtonARWoolleyTW.Attitudes of pharmacists toward mental illness and providing pharmaceutical care to the mentally III. Ann Pharmacother. 2005;39(9):1450-1455. doi:10.1345/aph.1G009
36.
LiekensSSmitsTLaekemanGFoulonV.Factors determining social distance toward people with depression among community pharmacists. Eur Psychol. 2012;27(7):528-535.
37.
MorralKMorralJ.A survey of community pharmacists’ attitudes towards mental illness. J Public Ment Health. 2016;15(2):93-102. doi:10.1108/JPMH-12-2015-0052
38.
AkourAHalloushSNusairMB, et al. Gaps in pharmaceutical care for patients with mental health issues: a cross-sectional study. Int J Clin Pharm. 2022;44(4):904-913. doi:10.1007/s11096-022-01391-x
39.
FrickAOsaeLNgoS, et al. Establishing the role of the pharmacist in mental health: Implementing mental health first aid into the doctor of pharmacy core curriculum. Currents Pharm Educ Learning. 2021;13(6):608-615. doi:10.1016/j.cptl.2021.01.027
40.
Ogadi IheanachoCOdiliVU. Pharmacy practice in various practice settings: the pharmacists’ perspective. Ind J Pharm Pract. 2021;14(1):14-19. doi:10.5530/ijopp.14.1.4
41.
WorleyMMSchommerJCBrownLM, et al. Pharmacists’ and patients’ roles in the pharmacist-patient relationship: are pharmacists and patients reading from the same relationship script?Res Soc Adm Pharm. 2007;3(1):47-69. doi:10.1016/j.sapharm.2006.03.003
42.
CrossnohereNLJanseSJanssenEBridgesJFP. Comparing the preferences of patients and the general public for treatment outcomes in type 2 diabetes mellitus. Patient. 2021;14(1):89-100. doi:10.1007/s40271-020-00450-7
43.
GagnonMDWaltermaurerEMartinA, et al. Patient beliefs have a greater impact than barriers on medication adherence in a community health center. J Am Board Fam Med. 2017;30(3):331-336. doi:10.3122/jabfm.2017.03.160129
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
